These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15455193)

  • 41. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
    Iwamoto J; Takeda T; Ichimura S; Uzawa M
    J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A clinical tool to determine the necessity of spine radiography in postmenopausal women with osteoporosis presenting with back pain.
    Roux C; Priol G; Fechtenbaum J; Cortet B; Liu-Léage S; Audran M
    Ann Rheum Dis; 2007 Jan; 66(1):81-5. PubMed ID: 16793842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteoporotic vertebral fractures in postmenopausal women.
    Millard PS; Rosen CJ; Johnson KH
    Am Fam Physician; 1997 Mar; 55(4):1315-22. PubMed ID: 9092292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women.
    Leidig-Bruckner G; Limberg B; Felsenberg D; Bruckner T; Holder S; Kather A; Miksch J; Wüster C; Ziegler R; Scheidt-Nave C
    Osteoporos Int; 2000; 11(2):102-19. PubMed ID: 10793868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Vertebral fracture: a major risk factor for osteoporosis].
    Krieg MA; Lamy O
    Praxis (Bern 1994); 2004 Feb; 93(9):321-8. PubMed ID: 15060973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome.
    Rico H; Hernandez ER; Revilla M; Gómez-Castresana F
    Bone Miner; 1992 Feb; 16(2):131-8. PubMed ID: 1576488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of new vertebral fracture in the year following a fracture.
    Lindsay R; Silverman SL; Cooper C; Hanley DA; Barton I; Broy SB; Licata A; Benhamou L; Geusens P; Flowers K; Stracke H; Seeman E
    JAMA; 2001 Jan; 285(3):320-3. PubMed ID: 11176842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A model of osteoporosis impact in Switzerland 2000-2020.
    Schwenkglenks M; Lippuner K; Häuselmann HJ; Szucs TD
    Osteoporos Int; 2005 Jun; 16(6):659-71. PubMed ID: 15517190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescribing by general practitioners after an osteoporotic fracture.
    Torgerson DJ; Dolan P
    Ann Rheum Dis; 1998 Jun; 57(6):378-9. PubMed ID: 9771215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules.
    Inoue T; Fujita T; Kishimoto H; Makino T; Nakamura T; Nakamura T; Sato T; Yamazaki K
    J Bone Miner Metab; 2009; 27(1):66-75. PubMed ID: 19082528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis.
    Krege JH; Siminoski K; Adachi JD; Misurski DA; Chen P
    Osteoporos Int; 2006; 17(3):379-86. PubMed ID: 16328604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis.
    Hansen MA; Overgaard K; Nielsen VA; Jensen GF; Gotfredsen A; Christiansen C
    Osteoporos Int; 1992 Sep; 2(5):241-6. PubMed ID: 1392263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognition of osteoporosis by primary care physicians.
    Gehlbach SH; Fournier M; Bigelow C
    Am J Public Health; 2002 Feb; 92(2):271-3. PubMed ID: 11818304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secular trends in the incidence of postmenopausal vertebral fractures.
    Cooper C; Atkinson EJ; Kotowicz M; O'Fallon WM; Melton LJ
    Calcif Tissue Int; 1992 Aug; 51(2):100-4. PubMed ID: 1422947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiological burden of postmenopausal osteoporosis in Italy from 2010 to 2020: estimations from a disease model.
    Piscitelli P; Brandi M; Cawston H; Gauthier A; Kanis JA; Compston J; Borgström F; Cooper C; McCloskey E
    Calcif Tissue Int; 2014 Nov; 95(5):419-27. PubMed ID: 25200337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group.
    Cooper C; Shah S; Hand DJ; Adams J; Compston J; Davie M; Woolf A
    Osteoporos Int; 1991 Oct; 2(1):48-53. PubMed ID: 1790421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isoflavones versus hormone therapy for reduction of vertebral fracture risk: indirect comparison.
    Bolaños R; Francia J
    Menopause; 2010; 17(6):1201-5. PubMed ID: 20613672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Health state utility values of osteoporotic fractures among Korean women.
    Bae G; Kim E; Kwon HY; An J; Park J; Yang H
    Expert Rev Pharmacoecon Outcomes Res; 2020 Apr; 20(2):177-183. PubMed ID: 31092075
    [No Abstract]   [Full Text] [Related]  

  • 59. Functional impairment among elderly women with osteoporotic vertebral fractures.
    Galindo-Ciocon D; Ciocon JO; Galindo D
    Rehabil Nurs; 1995; 20(2):79-83. PubMed ID: 7709048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk and clinical predictors of osteoporotic fracture in East Asian patients with chronic obstructive pulmonary disease: a population-based cohort study.
    Lee PH; Kok VC; Chou PL; Ku MC; Chen YC; Horng JT
    PeerJ; 2016; 4():e2634. PubMed ID: 27812429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.